Lupin said it is preparing for the launch of NaMuscla in Germany and the UK in Q1 2019, while looking for partners to commercialise the drug in rest of the European territories.from Moneycontrol Business News http://bit.ly/2TAHTRs
Monday, January 7, 2019
Lupin gets EU nod for specialty drug to treat rare neuromuscular disorder
Lupin said it is preparing for the launch of NaMuscla in Germany and the UK in Q1 2019, while looking for partners to commercialise the drug in rest of the European territories.from Moneycontrol Business News http://bit.ly/2TAHTRs
Subscribe to:
Post Comments (Atom)
-
The value had touched a high of 22% of total market capitalisation of listed firms in June 2009, dropping to a low of 5.1% in September 2020...
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment